866-997-4948(US-Canada Toll Free)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 127 Pages

Notes:
Production, means the output of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Revenue, means the sales value of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

This report studies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine
Split by application, this report focuses on consumption, market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in each application, can be divided into
Hospitals
Clinics
Others

Table of Contents

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017
1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
1.2.1 Global Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2015
1.2.2 Preface
1.2.3 Eluxadoline
1.2.4 Alosetron
1.2.5 Rifaximin
1.2.6 Loperamide
1.2.7 Diphenoxylate + Atropine
1.2.8 Dicyclomine and Hyoscyamine
1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application
1.3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application in 2015
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)

2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Manufacturers
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends
2.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate
2.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue (Value) by Region (2012-2017)
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Region (2012-2017)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions (2012-2017)
4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Type (2012-2017)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2012-2017)
5.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth by Type (2012-2017)

6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis by Application
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Profiles/Analysis
7.1 Astellas Pharmaceuticals
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
7.1.2.1 Preface
7.1.2.2 Eluxadoline
7.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Actavis
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
7.2.2.1 Preface
7.2.2.2 Eluxadoline
7.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
7.3.2.1 Preface
7.3.2.2 Eluxadoline
7.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
7.4.2.1 Preface
7.4.2.2 Eluxadoline
7.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Salix Pharmaceuticals Ltd
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
7.5.2.1 Preface
7.5.2.2 Eluxadoline
7.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 AstraZenenca
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification
7.6.2.1 Preface
7.6.2.2 Eluxadoline
7.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview

8 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis
8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2017-2022)
12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Price Forecast (2017-2022)
12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2017-2022)
12.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption , Import and Export Forecast by Regions (2017-2022)
12.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Global Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2015
Figure Product Picture of Preface
Table Major Manufacturers of Preface
Figure Product Picture of Eluxadoline
Table Major Manufacturers of Eluxadoline
Figure Product Picture of Alosetron
Table Major Manufacturers of Alosetron
Figure Product Picture of Rifaximin
Table Major Manufacturers of Rifaximin
Figure Product Picture of Loperamide
Table Major Manufacturers of Loperamide
Figure Product Picture of Diphenoxylate + Atropine
Table Major Manufacturers of Diphenoxylate + Atropine
Figure Product Picture of Dicyclomine and Hyoscyamine
Table Major Manufacturers of Dicyclomine and Hyoscyamine
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers
Figure 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers
Table Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 Manufacturers
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 5 Manufacturers
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions (2012-2017)
Figure 2015 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions (2012-2017)
Table 2015 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market by Regions (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Regions
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Application (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application in 2015
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (2015 and 2016)
Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (2015 and 2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (2015 and 2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (2015 and 2016)
Table Salix Pharmaceuticals Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (2015 and 2016)
Table AstraZenenca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
Table Major Buyers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Distributors/Traders List
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Growth Rate Forecast (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Forecast by Regions (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Regions (2017-2022)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *